Search results
Results from the WOW.Com Content Network
This was a "one-Baxter approach" in which the company provided "70% to 80% of what a hospital needed." [16] In 1991, Baxter's home infusion subsidiary, Caremark, "was accused by the government of paying doctors to steer patients to its intravenous drug service" [17] In 1992 Caremark spun off from Baxter International. [17]
Gambro is a global medical technology company that manufactures products for dialysis treatment. The company is involved in developing, manufacturing and supplying products and therapies for kidney and liver dialysis, myeloma kidney therapy [clarify], and other extracorporeal therapies for chronic and acute patients.
Baxter's Marion, North Carolina, site is among the largest suppliers of sterile intravenous fluids and peritoneal dialysis solutions in the U.S., making 1.5 million bags daily — 60% of the ...
Hemodialysis, also spelled haemodialysis, or simply dialysis, is a process of filtering the blood of a person whose kidneys are not working normally. This type of dialysis achieves the extracorporeal removal of waste products such as creatinine and urea and free water from the blood when the kidneys are in a state of kidney failure.
The cause for concern stems from the closing of the Baxter International plant in North Cove, North Carolina that makes IV fluids and peritoneal dialysis solutions which most of the country relies on.
Plasma-Lyte 148 is a market-specific solution available in the United Kingdom and Australia, among others and has the following composition: [citation needed] Sodium 140 mmol/L
Baxter International (NYS: BAX) announced today that it has agreed to buy privately held dialysis systems maker Gambro AB for approximately $4 billion in total consideration. In a statement ...
Baxter also has a Matching Gifts Program that provides employees with an opportunity to increase the impact of their charitable contributions to eligible organizations of their choice. [7] In 2013, Baxter and The Baxter International Foundation gave more than $64 million, including product donations, cash contributions and foundation grants.